Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Biofunctional thermoresponsive gelatin-PNIPAm microcarriers with embedded zero-valent iron nanoparticles for enhanced human adipose-derived stem cell expansion and differentiation.

Thammaniphit C., Wang PW., Wu YW., Tsai HY., Cheng YT., Lin XT.

Laboratory Study on Immune Modulation, published in Biomater Adv (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Biomater Adv (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41797091
DOI
10.1016/j.bioadv.2026.214791

Abstract (original English)

Human adipose-derived stem cells (ADSCs) hold substantial promise for regenerative medicine due to their multipotency and immunomodulatory capacity; however, efficient and scalable expansion remains a critical bottleneck. Conventional microcarrier culture systems typically rely on enzymatic dissociation for cell harvesting, which can compromise stemness, reduce viability, and limit process robustness. Here we report a thermoresponsive, magnetically responsive microcarrier platform (ZVI-GMC) comprising a gelatin core functionalized with poly(N-isopropylacrylamide)-allylamine (PNIPAm-ALA) and embedded zero-valent iron nanoparticles (ZVI NPs). The gelatin-PNIPAm-ALA hybrid interface enables temperature-triggered, enzyme-free cell detachment, supporting repeated passaging of ADSCs while preserving their viability, phenotype, and differentiation potential. Incorporation of ZVI NPs enhances structural stability, imparts magnetic responsiveness for facile handling, and promotes ADSCs proliferation under dynamic culture conditions. ADSCs cultured on ZVI-GMC microcarriers retained robust trilineage differentiation capacity toward osteogenic, adipogenic, and chondrogenic lineages, as confirmed by Alizarin Red S, Oil Red O, and Alcian Blue staining, respectively. Collectively, this macromolecule-nanoparticle hybrid microcarrier system provides a scalable and bioactive strategy for ADSCs e

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansGelatinAcrylic ResinsCell DifferentiationStem CellsAdipose TissueCell ProliferationIronTemperatureMetal Nanoparticles

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research